Menu Item

learn more

NJ's New Incentive Law: What Does It Mean?

New Jersey is finally stepping up with robust incentives tools – totaling $14 billion over six years.

learn more

RR&D and BrainStorm Cell Therapeutics Announce Agreement

Rapid Reshore & Development and BrainStorm Cell Therapeutics announce agreement to advance construction of BrainStorm's U.S. manufacturing facility.

learn more

The Rise Of Gene & Cell Therapy

Location demands emerge in experimental medicine as biopharma companies urgently seek expansion sites in commercial hubs across the U.S.

learn more

Reserve Your Seat for Our Webinar: Corporate Incentive Agreements During COVID-19

BLS & Co.'s Jay Biggins and Joe Lacy will share insight on corporate incentive compliance during COVID-19.

learn more

Reshoring in the Age of a Global Pandemic

Here’s how to approach site selection of a U.S. facility as businesses move to shore up supply chains.

learn more

Advanced Manufacturing Moment: Making Supplies For The War On COVID-19

BLS & Co.'s Michelle Comerford was recently interviewed by Forbes on how manufacturing is changing due to Coronavirus.

right pointing arrow